Inherited metabolic disorders and stroke part 2: Homocystinuria, organic acidurias, and urea cycle disorders

Archives of Neurology

Volumn 67, Issue 2, 2010, Pages 148-153

  Testai, Fernando D ^a   Gorelick, Philip B ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; ARGININE; ASCORBIC ACID; BENZOIC ACID; BETAINE; CARBOXYLIC ACID; CARNITINE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTINE; PHENYLACETATE SODIUM; PYRIDOXAL 5 PHOSPHATE; PYRIDOXINE; RIBOFLAVIN; UNCLASSIFIED DRUG; UREA; VITAMIN B COMPLEX;

ACIDURIA; BRAIN DISEASE; BRANCHED CHAIN ORGANIC ACIDURIA; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; DRUG MEGADOSE; FABRY DISEASE; GENETIC DISORDER; GLUTARIC ACIDURIA TYPE 1; HOMOCYSTINURIA; HUMAN; INCIDENCE; INHERITANCE; LACTIC ACIDOSIS; LOW DRUG DOSE; METABOLIC DISORDER; MITOCHONDRIAL MYOPATHY; MULTIPLE ACYL COA DEHYDROGENASE DEFICIENCY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; STROKE; SYMPTOM; THROMBOEMBOLISM; UREA CYCLE DISORDER;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HOMOCYSTINURIA; HUMANS; METABOLISM, INBORN ERRORS; MODELS, BIOLOGICAL; STROKE; UREA CYCLE DISORDERS, INBORN;

EID: 76149087434     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2009.333     Document Type: Review

References (42)

1. Testai FD, Gorelick PB. Inherited metabolic disorders and stroke part 1: Fabry disease and mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Arch Neurol. 2010;67(1):19-24.
2. Kraus JP, Janosík M, Kozich V, et al. Cystathionine β-synthase mutations in homocystinuria. Hum Mutat. 1999;13(5):362-375.
3. Online Mendelian Inheritance in Man. Homocystinuria. http://www.ncbi.nlm. nih.gov/entrez/dispomim.cgi?id=236200. Accessed March 27, 2009.
4. Mudd SH, Skovby F, Levy HL, et al. The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am J Hum Genet. 1985;37(1):1-31.
5. Lentz SR. Mechanisms of homocysteine-induced atherothrombosis. J Thromb Haemost. 2005;3(8):1646-1654.
6. Abahji TN, Nill L, Ide N, Keller C, Hoffmann U, Weiss N. Acute hyperhomocysteinemia induces microvascular and macrovascular endothelial dysfunction. Arch Med Res. 2007;38(4):411-416.
7. Upchurch GR Jr, Welch GN, Fabian AJ, et al. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem. 1997;272(27):17012-17017.
8. Dayal S, Wilson KM, Leo L, Arning E, Bottiglieri T, Lentz SR. Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia. Blood. 2006;108(7):2237-2243.
9. Kelly PJ, Furie KL, Kistler JP, et al. Stroke in young patients with hyperhomocysteinemia due to cystathionine β-synthase deficiency. Neurology. 2003;60(2):275-279.
10. Chauveheid MP, Lidove O, Papo T, Laissy JP. Adult-onset homocystinuria arteriopathy mimics fibromuscular dysplasia. Am J Med. 2008;121(9):e5-e6. Accessed March 8, 2009.
11. Blum A, Hijazi I, Eizenberg MM, Blum N. Homocysteine (Hcy) follow-up study. Clin Invest Med. 2007;30(1):21-25.
12. Yap S, Boers GH, Wilcken B, et al. Vascular outcome in patients with homocystinuria due to cystathionine β-synthase deficiency treated chronically: a multicenter observational study. Arterioscler Thromb Vasc Biol. 2001;21(12):2080-2085.
13. Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 2004;291(5):565-575.
14. Ogier de Baulny H, Saudubray JM. Branched-chain organic acidurias. Semin Neonatol. 2002;7(1):65-74.
15. Dave P, Curless RG, Steinman L. Cerebellar hemorrhage complicating methylmalonic and propionic acidemia. Arch Neurol. 1984;41(12):1293-1296.
16. Fischer AQ, Challa VR, Burton BK, McLean WT. Cerebellar hemorrhage complicating isovaleric acidemia: a case report. Neurology. 1981;31(6):746-748.
17. Haas RH, Marsden DL, Capistrano-Estrada S, et al. Acute basal ganglia infarction in propionic acidemia. J Child Neurol. 1995;10(1):18-22.
18. Chemelli AP, Schocke M, Sperl W, Trieb T, Aichner F, Felber S. Magnetic resonance spectroscopy (MRS) in five patients with treated propionic acidemia. J Magn Reson Imaging. 2000;11(6):596-600.
19. Trinh BC, Melhem ER, Barker PB. Multi-slice proton spectroscopy and diffusion-weighted imaging in methylmalonic acidemia: report of two cases and review of the literature. AJNR Am J Neuroradiol. 2001;22(5):831-833.
20. Bergman AJ, Van der Knaap MS, Smeitink JA, et al. Magnetic resonance imaging and spectroscopy of the brain in propionic acidemia: clinical and biochemical considerations. Pediatr Res. 1996;40(3):404-409.
21. Zschocke J, Hoffmann GF. Vademecum Metabolicum: Manual of Metabolic Paediatrics. 2nd ed. Stuttgart, Germany: Schattauer Verlag; 2004.
22. Shigematsu Y, Hata I, Nakai A, et al. Prenatal diagnosis of organic acidemias based on amniotic fluid levels of acylcarnitines. Pediatr Res. 1996;39(4, pt 1):680-684.
23. Shigematsu Y, Sudo M, Momoi T, Inoue Y, Suzuki Y, Kameyama J. Changing plasma and urinary organic acid levels in a patient with isovaleric acidemia during an attack. Pediatr Res. 1982;16(9):771-775.
24. Strauss KA, Puffenberger EG, Robinson DL, Morton DH. Type I glutaric aciduria, part 1: natural history of 77 patients. Am J Med Genet C Semin Med Genet. 2003;121C(1):38-52.
25. Kölker S, Garbade SF, Boy N, et al. Decline of acute encephalopathic crises in children with glutaryl-CoA dehydrogenase deficiency identified by newborn screening in Germany. Pediatr Res. 2007;62(3):357-363.
26. Pérez-Dueñas B, De La Osa A, Capdevila A, et al. Brain injury in glutaric aciduria type I: the value of functional techniques in magnetic resonance imaging. Eur J Paediatr Neurol. 2009;13(6):534-540.
27. Elster AW. Glutaric aciduria type I: value of diffusion-weighted magnetic resonance imaging for diagnosing acute striatal necrosis. J Comput Assist Tomogr. 2004;28(1):98-100.
28. Mühlhausen C, Ott N, Chalajour F, et al. Endothelial effects of 3-hydroxyglutaric acid: implications for glutaric aciduria type I. Pediatr Res. 2006;59(2):196-202.
29. Tortorelli S, Hahn SH, Cowan TM, Brewster TG, Rinaldo P, Matern D. The urinary excretion of glutarylcarnitine is an informative tool in the biochemical diagnosis of glutaric acidemia type I. Mol Genet Metab. 2005;84(2):137-143.
30. Kölker S, Christensen E, Leonard JV, et al. Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I). J Inherit Metab Dis. 2007;30(1):5-22.
31. Colevas AD, Edwards JL, Hruban RH, Mitchell GA, Valle D, Hutchins GM. Glutaric acidemia type II: comparison of pathologic features in two infants. Arch Pathol Lab Med. 1988;112(11):1133-1139.
32. Köppel S, Gottschalk J, Hoffmann GF, Waterham HR, Blobel H, Kölker S. Late-onset multiple acyl-CoA dehydrogenase deficiency: a frequently missing diagnosis? Neurology. 2006;67(8):1519.
33. Stöckler S, Radner H, Karpf EF, Hauer A, Ebner F. Symmetric hypoplasia of the temporal cerebral lobes in an infant with glutaric aciduria type II (multiple acyl-coenzyme A dehydrogenase deficiency). J Pediatr. 1994;124(4):601-604.
34. Vallée L, Fontaine M, Nuyts JP, et al. Stroke, hemiparesis and deficient mitochondrial β-oxidation. Eur J Pediatr. 1994;153(8):598-603.
35. Gordon N. Glutaric aciduria types I and II. Brain Dev. 2006;28(3):136-140.
36. Summar ML, Dobbelaere D, Brusilow S, Lee B. Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21-year, multicentre study of acute hyperammonaemic episodes. Acta Paediatr. 2008;97(10):1420-1425.
37. Keegan CE, Martin DM, Quint DJ, Gorski JL. Acute extrapyramidal syndrome in mild ornithine transcarbamylase deficiency: metabolic stroke involving the caudate and putamen without metabolic decompensation. Eur J Pediatr. 2003;162(4):259-263.
38. Sperl W, Felber S, Skladal D, Wermuth B. Metabolic stroke in carbamyl phosphate synthetase deficiency. Neuropediatrics. 1997;28(4):229-234.
39. Choi JH, Kim H, Yoo HW. Two cases of citrullinaemia presenting with stroke. J Inherit Metab Dis. 2006;29(1):182-183.
40. Christodoulou J, Qureshi IA, McInnes RR, Clarke JT. Ornithine transcarbamylase deficiency presenting with strokelike episodes. J Pediatr. 1993;122(3):423-425.
41. Steiner RD, Cederbaum SD. Laboratory evaluation of urea cycle disorders. J Pediatr. 2001;138(1)(suppl):S21-S29.
42. McBride KL, Miller G, Carter S, Karpen S, Goss J, Lee B. Developmental outcomes with early orthotopic liver transplantation for infants with neonatal-onset urea cycle defects and a female patient with late-onset ornithine trans-carbamylase deficiency. Pediatrics. 2004;114(4):e523-e526. Accessed November 9, 2009.